ProQR Therapeutics (PRQR) Revenue (2021 - 2025)
ProQR Therapeutics recorded quarterly Revenue of $5.5 million in Q4 2025, up 61.97% quarter-over-quarter from $3.4 million in Q3 2025, and up 18.57% year-over-year from $4.6 million in Q4 2024.
ProQR Therapeutics' Revenue history runs 5 years deep, the most recent figure standing at $5.5 million for Q4 2025.
- In Q4 2025, Revenue rose 18.57% year-over-year to $5.5 million; the TTM figure through Dec 2025 stood at $17.9 million (down 12.45% YoY), while the FY2025 annual figure was $18.5 million, down 8.35% from the prior year.
- Revenue came in at $5.5 million for Q4 2025 at ProQR Therapeutics, up from $3.4 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $6.8 million in Q2 2024 to a low of $273409.1 in Q4 2021.
- A 5-year average of $2.7 million and a median of $1.5 million in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue plunged 44.57% in 2023 and jumped 587.63% in 2024, its largest moves.
- ProQR Therapeutics' Revenue stood at $273409.1 in 2021, then soared by 168.67% to $734578.1 in 2022, then surged by 381.01% to $3.5 million in 2023, then soared by 30.26% to $4.6 million in 2024, then gained by 18.57% to $5.5 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $5.5 million, $3.4 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.46 Mn |
| Sep 30, 2025 | 3.37 Mn |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 4.75 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 4.22 Mn |
| Jun 30, 2024 | 6.79 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 703,038.89 |
| Dec 31, 2022 | 734,578.10 |
| Sep 30, 2022 | 820,735.30 |
| Jun 30, 2022 | 992,362.72 |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 273,409.06 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 292,637.96 |